CD19 and B-cell chronic lymphocytic leukemia: A sample with 53% CLL B cells proved inadequate, as the low-burden pathogenic mutation (c.825_826del (p.(A276Lfs*29)) was not detected by NGS, whereas both low- and high-burden mutations were detected in the CD19+ fraction.